A recap and summary of the two day course, covering: • Medical devices and diagnostics • Industrial applications and CleanTech • Aquaculture • Agriculture • Further reading and resources

1. Biotech Boot Camp
Session 5 – Summary and wrap-up
Presenter: Nick Weston
Melbourne, Brisbane, Sydney
28 May – 18 June, 2014

2. • Summary
• Wrap-up
2
Session 5 Overview
Summary and wrap-up

3. • Summary
• Wrap-up
3
Session 5 Overview
Summary and wrap-up

4. • Medical devices and diagnostics
• Industrial applications and clean-tech
• Life sciences
• Aquaculture and agriculture
Biotechnology
4
Summary

5. • Medical devices and diagnostics
• Industrial applications and clean-tech
• Life sciences
• Aquaculture and agriculture
Biotechnology
5
Summary

6. • A payer-driven focus on outcomes is driving device
developers away from a focus on services delivered to an
emphasis on achieving measurable results in patient
health during entire episodes of care
• A move to simple inexpensive consumer technologies
that allow bypass of expensive and complex health
information systems and can be a tool for improving care
once patients are discharged from hospital
Biotechnology
6
Medical devices and diagnostics

7. • Medical devices and diagnostics
• Industrial applications and clean-tech
• Life sciences
• Aquaculture and agriculture
Biotechnology
7
Summary

8. • A shift from petroleum-based economy combined with the
exhaustion and soaring price of petroleum has resulted in
an increased consumer awareness in the environmental
impact of global warming (greenhouse gas, CO2 emission
and pollution)
• A move towards the development of renewable source-
based bio-process and the replacement of chemical
processes with bio-based ones
Biotechnology
8
Industrial applications and cleantech

9. • Medical devices and diagnostics
• Industrial applications and clean-tech
• Life sciences
• Aquaculture and agriculture
Biotechnology
9
Summary

10. • Next-generation sequencing and use of big-data
analytics will increasingly be considered in diagnoses
and treatment decisions
• Immunotherapies, gene therapies, stem cell therapies
and systems biology approaches are leading the charge
into the genomics era
Biotechnology
10
Life sciences

11. • Medical devices and diagnostics
• Industrial applications and clean-tech
• Life sciences
• Aquaculture and agriculture
Biotechnology
11
Summary

12. • A move away from traditional practice of cultivating the
soil, producing crops, and raising livestock, agriculture is
employing GM techniques to enhance traits of plants and
animals and increase the yield and productivity of crops
whilst protecting the environment from harm
• Agriculture and aquaculture are embracing biotechnology
advances and allowing further development of
biotechnological applications for use in medicines,
diagnostics and life sciences
Biotechnology
12
Agriculture and aquaculture

13. • Summary
• Wrap-up
13
Session 5 Overview
Summary and wrap-up

14. Biotechnology
14
Wrap-up – IPOs in 2013 by market segment
Source: Burrill Transforming Healthcare Report 2014
• 2013 best year fro biotech
since 2000
• Globally, 65 IPOs completed
• 7.5 billion raised
• In U.S. 52 companies raised 7
billion on IPO (cf. 2012 where 16
companies raised 1.1B)

15. Biotechnology
15
Wrap-up – companies are going public earlier
Source: Burrill Transforming Healthcare Report 2014
Examples:
• Epizyme (epigenetics) $88.7M
• Bluebird Bio (gene therapy)
$101M
• Stemline Therapeutics
(oncology stem cell) $38M
• OncoMed Pharmaceuticals
(oncology stem cell) $93.8M

16. Biotechnology
16
Wrap-up – it is not just human therapeutics doing well
*Source: Burrill Transforming Healthcare Report 2014
Examples:
• January 2013 – Zoetis, an animal health company (carved out of drug
maker Pfizer Inc.) raised about US$2.2 billion in an IPO
• May 2013 - Kamada, the maker of an inhalation device to treat the
rare disease alpha-1 antitrypsin deficiency, raised $59.9 million in a
Nasdaq IPO*
• June 2013 - Aratana Therapeutics, an animal health company raised
$57.5 million in a Nasdaq IPO
• November 2013 - Evogene, an ag-biotech focussed on developing
improved crop traits, raised $84.8 million in a NYSE IPO*

17. Biotechnology
17
Wrap-up – M&A in 2013 by market segment (U.S.)
Source: Burrill Transforming Healthcare Report 2014

18. Biotechnology
18
Wrap-up – Performance of top Australian companies in
2013
Source: Burrill Transforming Healthcare Report 2014

19. Biotechnology is a rapidly maturing and global sector
Where once it was dependent on passing muster with
regulators, its success is increasingly tied to payers
Deal-making remains highly active
Biotech companies have become subsumed into the
broader economy (energy markets, food security,
healthcare ecosystems) that they must understand to do
well
Biotechnology
19
Wrap-up

20. Biotechnology
20
Further resources
• http://www.ich.org/products/guidelines.html (these guidelines are
frequently referenced during the day development process, and
cover the manufacturing, nonclinical and clinical requirements;
use only some of parts of them depending on product)
• www.tga.gov.au (regulatory, Australia)
• www.fda.gov (regulatory, USA)
• www.fda.gov/MedicalDevices/ (medical devices regulatory, USA)
• www.ema.europa.eu/ema/ (regulatory, Europe)
• www.ausbiotech.org (Australia’s biotechnology industry
association)

21. Biotechnology
21
Further resources
• www.ncbi.nlm.nih.gov/ (access to biomedical and genomic
information at the U.S. National Center for Biotechnology
Information)
• www.ncbi.nlm.nih.gov/pubmed (subscription only publication
database for biomedical literature)
• www.australian-aquacultureportal.com/ (portal to Australian
aquaculture news and resources)
• www.nal.usda.gov/ (US Department of Agriculture’s National
Agricultural Library, the most comprehensive ag. resource)
• www.crops.org (website of the Crops Science Society of America,
news, publications, insights)
• www.ars.usda.gov/main/main.htm (US Gov. Agriculture Research
Service)

22. Biotechnology
22
Further resources
• www.biomelbourne.org/vicbioportal (lists Victorian companies
providing services to the sector)
• www.stemcellsaustralia.edu.au/ (resources on stem cell
technology)
• www.innovation.gov.au/industry/biotechnology/ (biotech related
resources and links)
• www.nhmrc.gov.au/ (Australia’s National Health and Medical
Research Council)
• www.biotechnologyonline.gov.au/ (Basic resource covering
Australian biotech sector and technologies)

23. Biotechnology
23
Further resources
• www.ipaustralia.gov.au/ (search engines for patents, designs and
trade mark registrations in Australia)
• www.wipo.int/portal/en/index.html (search engine for patents,
designs and trade mark registrations internationally)
• www.fiercebiotechresearch.com/ www.fiercebiotechresearch.com/
www.fiercebiotech.com/ www.fiercediagnostics.com/
www.fiercemedicaldevices.com/ (biotech sectoral news and
insights)
• www.buildingbiotechnology.com/ (starting, building and operating
a biotechnology business)
• www.fao.org/biotech/biotech-glossary/en/ (glossary of
biotechnology terms)

24. Nick Weston
T: +61 3 8616 0379
mail@nicholasweston.com
Viktoriia Hristova
T: +61 3 8616 0380
viktoriia@nicholasweston.com
www.nicholasweston.com
Wrap-up
24
THANK YOU